Frontlight ResearchEarly access
Trial site
Bacs-Kiskun Varmegyei Oktatokorhaz
- 4closed trials
The trials here
What the 4 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease1 trial
- Depression1 trial
- Rheumatoid arthritis1 trial
- Schizophrenia1 trial
- Phase
- Phase 33 trials
- Phase 21 trial
- Status
- Completed4 trials
- Lead sponsor
- Alfasigma S.p.A.1 trial
- Cerevel Therapeutics LLC1 trial
- Janssen Cilag International1 trial
- Otsuka Pharmaceutical Development & Commercialization Inc.1 trial
Closed trials
Completed
Completed
A 52-week, Open-label Trial of CVL-231 in Adult Participants With Schizophrenia
Completed
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 12 Nov 2026